Clinical Trial Update: Phase III/Seroquel SR Bipolar Depression Monotherapy - US [Phase 3]

View source ↗

Summary

Completed Phase III trial evaluating Seroquel SR as monotherapy for bipolar depression in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder Depressive Episode

Drugs mentioned

• Seroquel SR (quetiapine extended-release)

Snippet

Sponsor: AstraZeneca | Conditions: Affective Psychosis, Bipolar, Depression, Bipolar | Phase 3 | Status: COMPLETED